Innovative Tablet Solutions: Veltio Pharma Showcases AstaReal® Astaxanthin at Vitafoods Europe

Vitafoods Europe is a key event for the nutraceutical industry, where companies present new products and formulations that meet growing consumer demands for health, sustainability, and simplicity. At this year’s event, Veltio Pharma introduced a new concept tablet featuring AstaReal® Astaxanthin, a plant-based antioxidant known for its health benefits. This tablet combines clean-label ingredients with a proprietary porous algae-based cellulose, reflecting Veltio Pharma’s focus on functionality and sustainability.

Veltio Pharma's innovative tablet featuring AstaReal® Astaxanthin

A New Approach to Tablet Formulation

Veltio Pharma’s new tablet concept stands out by using AstaReal® Astaxanthin, a powerful antioxidant derived from microalgae. Astaxanthin is valued for its potential to support skin health, eye health, and overall cellular protection. Unlike synthetic alternatives, AstaReal® offers a natural, plant-based source that fits well with clean-label trends.

The tablet’s base uses Veltio Pharma's proprietary porous algae-based cellulose. This ingredient serves multiple purposes:

• Acts as a natural binder and filler

• Enhances tablet stability and texture

• Supports sustainability by using renewable algae resources

  
  

This approach aligns with consumer preferences for simple, recognizable ingredients without artificial additives.

AstaReal® Astaxanthin

Astaxanthin is a carotenoid pigment found in certain algae and seafood, known for its strong antioxidant properties. Research suggests it may help reduce oxidative stress and inflammation, which are linked to aging and chronic diseases. AstaReal® Astaxanthin is produced under strict quality controls to ensure purity and potency.

The formulation by Veltio Pharma guarantees a product that provides all the Astaxanthin benefits.